The following represents disclosure information provided by authors of this abstract. The ASCO-NCI-EORTC Annual Meeting on Molecular Markers in Cancer Planning Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Detecting and classifying circulating tumor cell subclasses from On-Q-ity microfluidic chips using a customized imaging platform.
Chunsheng Jiang
Stock Ownership - On-Q-ity
David Tims
Stock Ownership - On-Q-ity
Aladin Milutinovic
Stock Ownership - On-Q-ity
Oleg Gusyatin
Consultant or Advisory Role - On-Q-ity
Keith D. Merdek
Stock Ownership - On-Q-ity
Kam M. Sprott
Stock Ownership - On-Q-ity
Yi Dong
Stock Ownership - On-Q-ity
Michael Stocum
Employment or Leadership Position - On-Q-ity
Stock Ownership - On-Q-ity
Walter P. Carney
Consultant or Advisory Role - On-Q-ity
Stock Ownership - On-Q-ity